Inventor · disambiguated record
Brent R. Stockwell
Also filed as: STOCKWELL BRENT · STOCKWELL BRENT R
25 granted patents·38 pending applications·387 citations·filing 1998–2025
96Inventor score
Files withUNIV COLUMBIA26STOCKWELL BRENT R12COMBINATORX INC4BORISY ALEXIS3WHITEHEAD BIOMEDICAL INST3
Top patents by PatentIndex Score
63 records- 0197US6693125B2Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disordersCOMBINATORX INC·Filed 2001·Granted Feb 17, 2004·117 cites·43 claims
- 0297US6569853B1Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disordersCOMBINATORX INC·Filed 2000·Granted May 27, 2003·111 cites·38 claims
- 0393US7358262B2Identification of genotype-selective anti-tumor agentsWHITEHEAD BIOMEDICAL INST·Filed 2004·Granted Apr 15, 2008·28 cites·5 claims
- 0491US9580398B2Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disordersUNIV COLUMBIA·Filed 2013·Granted Feb 28, 2017·8 cites·3 claims
- 0591US7615554B2Erastin and erastin binding proteins, and uses thereofPROLEXYS PHARMACEUTICALS INC·Filed 2006·Granted Nov 10, 2009·30 cites·23 claims
- 0690US6846816B2Combinations of drugs for the treatment of neoplastic disordersCOMBINATORX INC·Filed 2003·Granted Jan 25, 2005·26 cites·13 claims
- 0789US10597381B2Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disordersUNIV COLUMBIA·Filed 2019·Granted Mar 24, 2020·3 cites·6 claims
- 0889US9695133B2Quinazolinone-based oncogenic-RAS-selective lethal compounds and their useUNIV COLUMBIA·Filed 2013·Granted Jul 4, 2017·8 cites·28 claims
- 0985US11192849B2Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disordersUNIV COLUMBIA·Filed 2019·Granted Dec 7, 2021·2 cites·8 claims
- 1083US10947188B2Small molecule ferroptosis inducersUNIV COLUMBIA·Filed 2019·Granted Mar 16, 2021·1 cites·19 claims
- 1183US7148216B2Combinations of drugs for the treatment of neoplastic disordersCOMBINATORX INC·Filed 2004·Granted Dec 12, 2006·9 cites·8 claims
- 1282US10233171B2Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disordersUNIV COLUMBIA·Filed 2017·Granted Mar 19, 2019·2 cites·26 claims
- 1381US10259775B2Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disordersUNIV COLUMBIA·Filed 2014·Granted Apr 16, 2019·2 cites·13 claims
- 1479US8546421B1Oncogenic-RAS-signal dependent lethal compoundsSTOCKWELL BRENT R·Filed 2009·Granted Oct 1, 2013·5 cites·4 claims
- 1574US8518959B2Quinoxaline derivatives as antitumor agentsBECKLIN ROBERT R·Filed 2006·Granted Aug 27, 2013·5 cites·17 claims
- 1674US7101879B2Treatments for neurotoxicity in Alzheimer's DiseaseWHITEHEAD BIOMEDICAL INST·Filed 2002·Granted Sep 5, 2006·5 cites·3 claims
- 1774US7067550B2Treatments for neurotoxicity in Alzheimer's DiseaseMASSACHUSETTS INST TECHNOLOGY·Filed 2002·Granted Jun 27, 2006·5 cites·2 claims
- 1872US8535897B2Assays for non-apoptotic cell death and uses thereofSTOCKWELL BRENT R·Filed 2007·Granted Sep 17, 2013·3 cites·12 claims
- 1971US9926293B2Multivalent RAS binding compoundsUNIV COLUMBIA·Filed 2016·Granted Mar 27, 2018·1 cites·10 claims
- 2070US6448443B1Synthesis of combinatorial libraries of compounds reminiscent of natural productsHARVARD COLLEGE·Filed 1998·Granted Sep 10, 2002·11 cites·8 claims
- 2169US7109377B2Synthesis of combinatorial libraries of compounds reminiscent of natural productsHARVARD COLLEGE·Filed 2002·Granted Sep 19, 2006·4 cites·6 claims
- 2269US2024156790A1Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disordersUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 2369US2007099906A1Combinations for the treatment of noeplastic disordersBORISY ALEXIS·Filed 2006·Application pending·0 cites
- 2465US8124365B2Identification of genotype-selective anti-tumor agentsSTOCKWELL BRENT R·Filed 2008·Granted Feb 28, 2012·0 cites·4 claims
- 2565US2009031435A1SMA Therapy and Cell Based AssaySTOCKWELL BRENT R·Filed 2007·Application pending·0 cites
- 2664US9938245B2Carbonyl erastin analogs and their useUNIV COLUMBIA·Filed 2015·Granted Apr 10, 2018·1 cites·25 claims
- 2763US2023035422A1Methods for treating diseases by targeting oncogenic lipidsUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 2861US12377107B2NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic leukemiaUNIV COLUMBIA·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 2961US12227500B2Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stressUNIV COLUMBIA·Filed 2020·Granted Feb 18, 2025·0 cites·87 claims
- 3061US2022412989A1Compositions and methods for detecting cells undergoing ferroptosis using an antibodyUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 3161US2023167058A1Gpx4 compounds and compositions and methods of treatment using sameUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 3260US2007099905A1Combinations of drugs for the treatment of neoplasmsBORISY ALEXIS·Filed 2006·Application pending·0 cites
- 3357US2021299107A1Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disordersUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 3457US2004044063A1SMA therapy and cell based assay for identifying therapiesFiled 2003·Application pending·0 cites
- 3556US2022380383A1Neuroprotective pdi modulating small molecules and methods of use thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 3655US2022119399A1Compounds and compositions that cause mycn and/or cmyc degradation and methods of use thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 3755US2021267978A1Nanoparticle formulations of ike and methods of use thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 3855US2004009495A1Methods and products related to drug screening using gene expression patternsWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
- 3955US2008299076A1Compunds and compositions that cause non-apoptotic cell death and uses thereofSTOCKWELL BRENT R·Filed 2008·Application pending·0 cites
- 4054US2004116407A1Combinations of drugs for the treatment of neoplasmsFiled 2003·Application pending·0 cites
- 4154US2006177877A1Methods for identifying combinations of entities as therapeuticsSTOCKWELL BRENT R·Filed 2006·Application pending·0 cites
- 4254US2025248979A1Novel gpx4 inhibitors and uses thereofUNIV COLUMBIA·Filed 2025·Application pending·0 cites
- 4354US2008194421A1Screening system for identifying drug-drug interactions and methods of use thereofBORISY ALEXIS·Filed 2008·Application pending·0 cites
- 4453US2023140200A1Compositions and methods for detecting cells undergoing ferroptosis using an antibodyUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 4553US2025382291A1SUBSTITUTED PYRROLO[2,3-b]PYRIDINES FOR SUPPRESSING TOXIC ENDOPLASMIC RETICULUM STRESSUNIV COLUMBIA·Filed 2025·Application pending·0 cites
- 4652US2007149543A1Agents For Treating Neurodegenerative DiseasesSTOCKWELL BRENT R·Filed 2006·Application pending·0 cites
- 4751US2007078144A1Agents for treating neurodegenerative diseasesSTOCKWELL BRENT R·Filed 2006·Application pending·0 cites
- 4850US2022193047A1Methods of enhancing radiotherapy using ferroptosis inducers as radiosensitizersUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 4950US2004063769A1Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disordersFiled 2003·Application pending·0 cites
- 5049US2007027164A1Agents for treating neurodegenerative diseasesSTOCKWELL BRENT R·Filed 2006·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →